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Abstract
Background Capsular fibrosis is a severe complication
after breast implantation with an uncertain etiology.
Microbial colonization of the prosthesis is hypothesized as a
possible reason for the low-grade infection and subsequent
capsular fibrosis. Current diagnostic tests consist of intra-
operative swabs and tissue biopsies. Sonication of removed
implants may improve the diagnosis of implant infection by
detachment of biofilms from the implant surface.
Methods Breast implants removed from patients with
Baker grades 3 and 4 capsular contracture were analyzed
by sonication, and the resulting sonication fluid was
quantitatively cultured.
Results This study investigated 22 breast implants (6
implants with Baker 3 and 16 implants with Baker 4
capsular fibrosis) from 13 patients. The mean age of the
patients was 49 years (range, 31–76 years). The mean
implant indwelling time was 10.4 years (range, 3 months
to 30 years). Of the 22 implants, 12 were used for breast
reconstruction and 10 for aesthetic procedures. The
implants were located subglandularly (n = 12), submus-
cularly (n = 6), and subcutaneously (n = 4). Coagulase-
negative staphylococci, Propionibacterium acnes, or both
were detected in the sonication fluid cultures of nine
implants (41%), eight of which grew significant numbers of
microorganisms ([100 colonies/ml of sonication fluid).
Conclusions Sonication detected bacteria in 41% of
removed breast implants. The identified bacteria belonged
to normal skin flora. Further investigation is needed to
determine any causal relation between biofilms and cap-
sular fibrosis.
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Periprosthetic capsular contracture is a severe complication
experienced by 30% of patients after breast prosthesis
implantation [5–7]. The etiology of capsular contracture
remains unclear. Implant filling, placement of the pros-
thesis, surface texture, and low-grade prosthesis infection
are hypothesized as influencing the formation of capsular
fibrosis and subsequent contracture [4].
We specifically investigated microbial colonization of
the implant as the possible cause for a persistent chronic
low-grade infection and subsequent formation of capsular
fibrosis, as previously suggested by other investigators
[7–9, 11]. This hypothesis is supported by the fact that
unilateral contractures may occur after bilateral augmen-
tation surgery with identical implants, making systemic
(host-related) and implant-specific causes less likely.
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Several studies aimed to detect adherent bacteria growing
in biofilms on breast implants, but no conclusive data were
published. Most of these studies used conventional swabs,
biopsies of the periprosthetic fibrotic capsule, or both, and
judged the results to be positive if at least one of several
samples yielded bacterial growth [2, 12]. This microbiologic
method, however, lacks sensitivity and specificity, as dem-
onstrated in other surgical specialties such as orthopedic
surgery [3]. Conventional swabs can be false-negative in
about 30% of cases with prosthetic joint infection, making this
method unreliable for detecting implant-associated infection.
Sonication of removed implants is a new diagnostic
method shown by our group to improve the diagnosis of
prosthetic joint infection significantly by detachment of
microbial biofilms from the hip and knee prosthetic surface
[14]. Furthermore, sonication of parts of breast implants and
capsule biopsies performed by Pajkos et al. [9] yielded posi-
tive cultures for 38.5% of implants and 89.5% of capsules
involving severely contracted breasts. We hypothesized that
sonication of whole-breast implants with an optimized soni-
cation method can improve the detection of microbial
colonization of removed breast implants and generate new
insights into the pathogenesis of capsular contracture.
Patients and Methods
Study Population
The study was conducted at the University Hospital Basel,
Switzerland, an 800-bed primary and tertiary health care
center. This hospital is the major provider of acute medical
care for about 300,000 inhabitants. The study enrolled
patients undergoing breast implant removal for Baker 3
and 4 capsular contracture in the Department of Plastic,
Reconstructive, and Aesthetic Surgery at the University
Hospital Basel, Switzerland between March 2007 and
February 2008. Patients were excluded if obvious con-
tamination occurred in the operating room.
Collection of Breast Implants
Whole-breast implants were aseptically removed from
the patient, and each was placed in a separate sterile
polyethylene container (Lock & Lock, HPL 933; Vetrag
AG, Sta¨fa, Switzerland). The reason for implant removal,
the implant type and placement, and the indwelling time of
the implant were recorded by the surgeon. The surgeon
assessed breast firmness using the Baker manual scaling
method [13].
Sonication of Breast Implants
In the microbiologic laboratory, 100 ml of sterile Ringer’s
solution was added to each container holding the breast
implant, which was processed within 6 h of removal
(Fig. 1). The container was vortexed for 30 s, then soni-
cated for 1 min at a frequency of 40 ± 2 kHz and a power
density of 0.22 ± 0.04 W/cm2, as determined by a cali-
brated hydrophone (Type 8103; Bru¨el and Kjær, Naerum,
Denmark).
For sonication, an ultrasound bath (BactoSonic; Ban-
delin GmbH, Berlin, Germany) was used. The resulting
sonication fluid was plated in aliquots of 0.1 ml onto aer-
obic and anaerobic sheep blood agar plates, incubated at
378C for 7 days, and inspected daily for bacterial growth.
Microorganisms were enumerated and classified using
routine microbiologic techniques. Positive sonication was
considered if 10 colony-forming units (CFU)/ml or more of
sonication fluid were detected.
Negative Control Implants
Three sterilized breast implants were included in the son-
ication process as negative control implants. These were
placed on the table with the surgical instruments in the
regular operating room. They subsequently were placed in
sterile polyethylene containers, then processed as described
earlier for implants collected from patients.
Results
Patient Characteristics
During the study period, 22 breast implants from 13 patients
were investigated (Table 1). At the time of implant removal,
the mean patient age was 49 years (range, 31–76 years). For
Fig. 1 Sonication procedure.
Aseptically removed breast
implants were placed in sterile
containers, then vortexed and
sonicated in Ringer’s solution
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4 implants (18%), previous implant replacement surgeries
had been performed before the current surgical procedure
due to capsular contracture, whereas for 18 implants (82%),
the current surgery was the first procedure after primary
breast implantation. The mean implant indwelling time
was 10.4 years (range, 3 months to 30 years). Of the 22
implants, 12 (55%) were used for breast reconstruction
and 10 (45%) for aesthetic procedures. At explantation, the
diagnosis was Baker 3 capsular contracture for 6 implants
(27%) and Baker 4 contracture for 16 implants (73%).
Implant Characteristics
In terms of placement, 12 implants were positioned
subglandularly, 6 submuscularly (partially), and 4 subcut-
anously (all reconstructions only) (Table 2). The surface
structure was textured for 16 implants (73%) and smooth
for 6 implants (27%). Of the 22 implants, 20 contained
silicone gel (high cohesive), and 2 contained silicone fluid
(low cohesive). The mean volume of the breast implants
was 230 ml (range, 130–750 ml).
Microbiology
Nine (41%) of the implants showed significant numbers of
bacteria growing in sonication fluid cultures ([10 CFU/ml
of sonication fluid). Coagulase-negative staphylococci were
identified on three implants, Propionibacterium acnes
on two implants, and both organisms (coagulase-negative
staphylococci and Propionibacterium acnes) on four
implants. On 8 (89%) of 9 implants with a positive sonica-
tion culture, high numbers of microorganisms ([100 CFU/
ml of sonication fluid) were detected, indicating a multiple-
layer biofilm on the prosthesis surface.
Negative Controls
None of the three sterile implants investigated by sonica-
tion showed any growth in the sonication fluid culture.
Conjoint Analysis of Implant Characteristics
and Microbiology
The colonization rates for implant surfaces with regard
to location of the implant (subglandular, submuscular,
subcutaneous placement), implant surface (smooth vs tex-
tured), type of implant (liquid [low cohesive] vs gel [high
cohesive] silicone), and implant volume (C250 vs \250
ml) are shown in Table 2. No significant differences in
colonization rates with biofilms were detected among the
aforementioned groups.
Discussion
Clinically manifested postoperative infection after breast
implant placement is rare [1]. However, considering the
hypothesis that subclinical infection plays a role in the
development of capsular fibrosis, the incidence of bacterial
colonization on breast implants may be much higher [7,
9, 10].
The bacteria identified in our study consisted exclu-
sively of skin flora. This finding has been confirmed by
others [9, 12]. Previous studies had failed to detect bacteria
consistently using swabs and tissue biopsies. The cultures
tested positive in 30% to 67% of cases [12]. It is difficult to
interpret the results of these studies because a single swab
or biopsy was considered positive, which may have rep-
resented contamination [2, 12].
Table 1 Patient characteristics
Characteristic Total (n = 22)
Age (years): mean (range) 49 (31–76)
Implant indwelling time (years): mean (range) 10.4 (0.25–30)
Preexisting breast disease: n (%)
Breast hypoplasia (aesthetic procedure) 12 (55)
Breast cancer (reconstructive procedure) 10 (45)
Capsular contracture: n (%)
Baker 3 6 (27)
Baker 4 16 (73)
Table 2 Implant characteristics and relative sonication results
Characteristic Total (n = 22) n
(%)
Positive sonication
results (n = 9) n (%)
Location of implant
Subglandular 12 (55) 5/12 (42)
Subpectoral 6 (27) 3/6 (50)
Subcutanous
(reconstructive)
4 (18) 1/4 (25)
Surface of implant
Textured 16 (73) 7/16 (44)
Smooth 6 (27) 2/6 (33)
Type of implant
Silicone gel (high
cohesive)
20 (91) 9/20 (45)
Silicone liquid (low
cohesive)
2 (9) 0/2 (0)
Volume of implant (ml)
\250 13 (59) 6/13 (46)
C250 5 (23) 3/5 (60)
Ruptured 4 (18) 0/4 (0)
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Pajkos et al. [9] have described the use of a sonication
method to detect biofilms on parts of breast implants and
on fibrotic capsule biopsies. This method yielded positive
culture results for 24 (50%) of 48 cases including Baker 1
and 2 contractures. In the analysis of Pajkos’ subgroups
(Baker 3 and 4 capsular contractures), the cultures of
capsule samples tested positive in 89% of cases, whereas
the implant pieces tested positive in 38.5% of cases.
The better sensitivity of sonication in detecting sub-
clinical infection and biofilms on orthopedic implants
compared with standard swabs and biopsies has been
confirmed by our group [14]. Because of the high sensi-
tivity, we aimed to apply the sonication method only to
implants causing Baker 3 and 4 capsular contracture
because these contractures yielded the highest numbers of
positive cultures in studies using conventional microbiol-
ogy [2, 12].
We found that 41% of implants showed significant
numbers of bacteria on the prosthesis surface. These results
in our series may seem inferior to the findings of Pajkos
et al. [9] and those of other studies yielding up to 67% of
colonized implants in patients with Baker 3 and 4 capsular
contractures. However, these results often were determined
from only one positive swab or biopsy, which may repre-
sent contamination, especially when bacteria from the skin
flora are involved. Therefore, in orthopedic surgery, at least
two tissue specimens must test positive before the results
are considered positive for low-virulent organisms. The
same holds true for blood cultures [3].
In addition, our sonication method allows quantification
of recovered bacteria in the sonication fluid, which can
distinguish between contamination during prosthesis
removal and biofilm infection of breast implants. Pajkos
et al. [9] quantified bacteria in seven samples from three
patients. In these seven samples, the numbers of bacterial
counts were highly variable. Therefore, in our opinion, an
accurate distinction between infection, typically compris-
ing a multilayer of biofilm, and a contamination, typically
involving low numbers of bacteria belonging to skin flora,
is possible only by quantifying the numbers of removed
bacteria after sonication. Our approach intended to avoid
sampling errors that may occur when portions of the
implant are sonicated instead of the whole implant.
Our study had some limitations, including a lack of
sonication of capsules (parts or complete), which may
detect bacteria in the culture for patients with Baker 3 and
4 capsular contractures. The sensitivity of the sonication
method could have been gained if whole capsules had been
sonicated. However, extirpation of whole capsules often
may not be feasible or desired from a surgical perspective.
In most cases, whole capsules were not available to us.
Sensitivity would be improved further if sonication for
breast implants were individually optimized because the
acoustic parameters may not be transferable directly from
mechanical orthopedic implants to breast implants due to
differences in material, surface structure, and density.
Conclusion
Sonication of whole implants may be a useful addition to
the armamentarium of procedures used to detect microor-
ganisms on breast implants. In our series, bacteria were
detected in 41% of removed breast implants. The identified
bacteria belonged to normal skin flora, which colonized the
implant either during implantation or later by lymphoge-
nous or hematogenous spread or by lactiferous duct
contamination. Further investigation is needed to determine
the causal relation between biofilms and capsular fibrosis.
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